Advertisement
Table 1 Group of Experiments
| Group | Treatment1 |
|---|---|
| 1 (Control) | PBS nose drops, 300 μL/per mouse |
| 2 (Infection) | H9N2 AIV nose drops, 300 μL/per mouse |
| 3 (Neongreen) | PBS nose drops, 300 μL/per mouse; intragastrical administration oflabeled bacteriaat 3 dpi, 300 μL/per mouse |
| 4 (Infected-Neongreen) | H9N2 AIV nose drops, 300 μL/per mouse; intragastrical administration oflabeled bacteriaat 3 dpi, 300 μL/per mouse |
| 5 (Ageratum-liquid) | PBS nose drops, 300 μL/per mouse; filled with ALat 2, 3, 4 dpi, 1 mL/100 g, perday |
| 6 (Infection-Ageratum-liquid) | H9N2 AIV nose drops, 300 μL/per mouse; filled with ALat 2, 3, 4 dpi, 1 mL/100 g, perday |
| 7 (Ageratum-liquid-Neongreen) | PBS nose drops, 300 μL/per mouse; filled with ALat 2, 3, 4 dpi, 1 mL/100 g, perday; intragastrical administration oflabeled bacteria at 3 dpi, 300 μL/per mouse |
| 8 (Infection-Ageratum-liquid-Neongreen) | H9N2 AIV nose drops, 300 μL/per mouse; filled with ALat 2, 3, 4 dpi, 1 mL/100 g, perday; intragastrical administration oflabeled bacteria at 3 dpi, 300 μL/per mouse |
